Genomic Characterization of the Chromosomal Breakpoints of T(4;14) of Multiple Myeloma Suggests More Than One Possible Aetiological Mechanism

Oncogene - United Kingdom
doi 10.1038/sj.onc.1206335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Diagnostic Evaluation of T(4;14) in Multiple Myeloma and Evidence for Clonal Evolution

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

CHIR-258, a Novel, Multitargeted Tyrosine Kinase Inhibitor for the Potential Treatment of T(4;14) Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Hypodiploid Multiple Myeloma Is Characterized by More Aggressive Molecular Markers Than Non-Hyperdiploid Multiple Myeloma

Haematologica
Hematology
2013English

A Rare Case of Multiple Myeloma With Intracranial Extramedullary Relapse: One or More Myeloma Clones?

Clinical Case Reports
Medicine
2019English

MB4-2 Breakpoint in MMSET Combined With Del(17p) Defines a Subset of T(4;14) Multiple Myeloma With Very Poor Prognosis

Haematologica
Hematology
2015English

Somatic Genomic Mosaicism in Multiple Myeloma

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

More Than One Bad Apple

Nature
Multidisciplinary
2008English

T(4;14)(p16;q32)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Mechanism of Action of Posttransplantation Cyclophosphamide: More Than Meets the Eye

Journal of Clinical Investigation
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy